Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles
Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy
MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

View More »

Google Scholar citation report
Citations : 2341

Journal of Vaccines & Vaccination received 2341 citations as per Google Scholar report

Journal of Vaccines & Vaccination
Journal of Vaccines & Vaccination peer review process verified at publons
Journal of Vaccines & Vaccination
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Open Access Journals
View More

Minal Barve

Minal Barve

Texas Oncology, P.A., Dallas, TX, USA

Biography
Dr. Barve is the Executive Medical Director and Chief Medical Officer for Mary Crowley Cancer Research in Dallas. Their focus is to develop novel treatments for cancer. She is also the Medical Director for GDAS (Greater Dallas Arya Samaj) Cancer Clinic, which provides care for indigent patients with curable cancers.
Research Interest
Dr. Barve is very involved in research. She is the principal investigator of several phase I, II and III clinical trials conducted by the Mary Crowley Medical Research Centers. Her special interests include early drug development and immunologic therapies for cancer. Outside of medicine, Dr Barve enjoys biking, traveling, music and spending time with her family.